DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Tiako Meyo M, Alexandre J, Goldwasser F, Blanchet B.
Low-dose abiraterone regimen: drug monitoring might be the key.
J Clin Oncol 2018;
36 (30) 3061-3062
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.